Long intergenic non-protein coding RNA 488 (LINC00488)

Long intergenic non-protein coding RNA 488 (LINC00488) is a long non-coding RNA (lncRNA), more specifically classified as a long intergenic non-coding RNA, which does not encode protein. LINC00488 has been implicated in the progression of various cancers, where it acts as an oncogenic lncRNA. Its molecular mechanism often involves functioning as a competitive endogenous RNA (ceRNA) that sponges specific microRNAs (such as miR-330-5p and miR-376a-3p), thereby modulating the expression levels of target genes involved in cell proliferation, apoptosis inhibition, angiogenesis, and metastatic properties. Higher LINC00488 expression is associated with poor prognostic outcomes in multiple cancers, including colorectal, hepatocellular, thyroid, and esophageal cancers[1][2][3][4][6]. LINC00488 is not a classical therapeutic target such as a receptor or enzyme, and there are currently no drugs known to directly target this lncRNA. However, its role in cancer biology makes it of interest as a potential biomarker and a possible future therapeutic target as research on lncRNA-targeted therapies advances[1][2][4].

Other names

FLJ41232C3orf66LINC00488